The NOD2 agonist muramyl-di-peptide (MDP) reverses the inhibitory effects of TLR4 activation on enterocyte proliferation through effects on beta-catenin signaling, and attenuates the severity of experimental necrotizing enterocolitis
Year: 2008
Type: article
Authors: Ward M. Richardson, Xiao-Hua Shi, Steven C. Gribar, Maria Branca, Theresa Dubowski, Jun Li, Chhindler Sodhi, David J. Hackam
Institution: University of Pittsburgh
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2092796629
